Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus Conversion in Liver Transplant for Renal Function
NCT01936519Phase 2Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Dec 2013
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in Liver transplant rejection, sponsored by Penn State Health Milton S. Hershey Medical Center. Started Dec 2013; status: completed.
02
Drugs
everolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT01936519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01936519.